---
title: General_overview_of_H.Pylori_resistance
layout: default
---

# General Overview of H. pylori Resistance

---

## Section 1: Dialogue Prompt
```
Task: Analyze H. pylori resistance by country from the project file
Source: Clinical Laboratory Analysis - 2023 - Lin - Antibiotic resistance in 
       Helicobacter pylori From potential biomolecular-1.pdf
Requirements: 
- Get resistance analysis by country
- Calculate mean, mode, median where possible
```

---

## Section 2: References
```
Publication: Yifan_Lin-Yongfu_Shao (2023)
Link: https://onlinelibrary.wiley.com/doi/10.1002/jcla.24885
```

---

## Section 3: Generated Output

### 1. Amoxicillin Resistance Data
<table>
<tr><th>Region/Country</th><th>Resistance (%)</th></tr>
<tr><td>Africa (overall)</td><td>72.6</td></tr>
<tr><td>Algeria</td><td>0.0</td></tr>
<tr><td>Cameroon</td><td>100.0</td></tr>
<tr><td>China</td><td>2.8</td></tr>
<tr><td>Vietnam</td><td>25.7</td></tr>
<tr><td>Europe (overall)</td><td>0.4</td></tr>
<tr><td>Spain</td><td>0.0</td></tr>
<tr><td>Italy</td><td>1.0</td></tr>
</table>

*Statistical Analysis: Insufficient consistent data for calculations*

### 2. Clarithromycin Resistance Data
<table>
<tr><th>Region</th><th>Resistance (%)</th></tr>
<tr><td>Africa</td><td>29.2</td></tr>
<tr><td>Americas</td><td>10.0</td></tr>
<tr><td>Eastern Mediterranean</td><td>33.0</td></tr>
<tr><td>Europe</td><td>18.0</td></tr>
<tr><td>Southeast Asia</td><td>10.0</td></tr>
<tr><td>Western Pacific</td><td>34.0</td></tr>
</table>

**Statistical Summary:**
```
Mean: 22.37%
Median: 23.5%
Mode: 10% (occurs twice)
```

### 3. Levofloxacin Resistance Data
<table>
<tr><th>Region/Country</th><th>Resistance (%)</th></tr>
<tr><td>Asia</td><td>18.0</td></tr>
<tr><td>China</td><td>30.3</td></tr>
<tr><td>Indonesia</td><td>31.0</td></tr>
<tr><td>India</td><td>54.9</td></tr>
<tr><td>Pakistan</td><td>15.2</td></tr>
<tr><td>Thailand</td><td>13.5</td></tr>
<tr><td>Japan</td><td>36.0</td></tr>
<tr><td>Europe</td><td>20.0</td></tr>
<tr><td>France</td><td>17.6</td></tr>
<tr><td>Germany</td><td>13.4</td></tr>
<tr><td>Spain</td><td>38.7</td></tr>
<tr><td>Americas</td><td>14.0</td></tr>
<tr><td>Brazil</td><td>11.1</td></tr>
<tr><td>USA</td><td>37.6</td></tr>
<tr><td>Africa</td><td>17.4</td></tr>
<tr><td>Congo</td><td>58.8</td></tr>
<tr><td>Nigeria</td><td>0.0</td></tr>
</table>

**Statistical Summary:**
```
Mean: 26.68%
Median: 18.0%
Mode: No clear mode
```

### 4. Metronidazole Resistance Data
<table>
<tr><th>Region/Country</th><th>Resistance (%)</th></tr>
<tr><td>Americas</td><td>23.0</td></tr>
<tr><td>Bangladesh</td><td>94.6</td></tr>
<tr><td>China</td><td>87.8</td></tr>
<tr><td>India</td><td>81.6</td></tr>
<tr><td>Japan</td><td>48.0</td></tr>
<tr><td>South Korea</td><td>27.1</td></tr>
<tr><td>Thailand</td><td>14.3</td></tr>
<tr><td>Vietnam</td><td>49.4</td></tr>
<tr><td>Europe</td><td>32.0</td></tr>
<tr><td>France</td><td>58.6</td></tr>
<tr><td>Austria</td><td>10.2</td></tr>
<tr><td>New Zealand/Australia</td><td>50.0</td></tr>
</table>

**Statistical Summary:**
```
Mean: 48.05%
Median: 48.7%
Mode: No clear mode
```

### 5. Tetracycline Resistance Data
<table>
<tr><th>Region/Country</th><th>Resistance (%)</th></tr>
<tr><td>China</td><td>1.2</td></tr>
<tr><td>Bhutan</td><td>0.6</td></tr>
<tr><td>Iran</td><td>8.0</td></tr>
<tr><td>India</td><td>5.3</td></tr>
<tr><td>Japan</td><td>2.0</td></tr>
<tr><td>Europe</td><td><1.0</td></tr>
<tr><td>Germany</td><td>2.5</td></tr>
<tr><td>Spain</td><td>0.0</td></tr>
<tr><td>USA</td><td>0.87</td></tr>
<tr><td>New Zealand/Australia</td><td>0.5</td></tr>
</table>

**Statistical Summary:**
```
Mean: 2.33% (excluding "<1%" for Europe)
Median: 1.2%
Mode: No clear mode
```

These calculations provide an overview of the resistance patterns across different countries and regions. Keep in mind that the data availability varies by antibiotic and country, which may affect the accuracy of the statistical measures.

---

## Section 4: Expected Output
